Mode
Text Size
Log in / Sign up
N/A N=244 Randomized Single-blind Other

Randomized Controlled Trial Comparing Adult to Pediatric Colonoscope in Obese Patients.

Obesity (Body Mass Index &Amp;Amp;gt;30 kg/m2) · Screening Colonoscopy

Enrolled (actual)
244
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Composite of Reaching the Cecum in Less Than 10 Minutes Without Changing the Scope Type. — 113; 116 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Colonoscopy (Device)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Cleveland Clinic Florida
Primary completion
Sep 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Composite of Reaching the Cecum in Less Than 10 Minutes Without Changing the Scope Type.
113; 116
SECONDARY
Number of Participants With Successful Advancement of Colonoscope to the Cecum
118; 119
SECONDARY
Number of Participants With Successful Advancement of Colonoscope to the Terminal Ileum
92; 96
SECONDARY
Time Taken to Advance the Colonoscope From the Rectum to the Cecum.
4.45; 4.20
SECONDARY
Time Taken to Withdraw Colonoscope From Cecum to Rectum (Withdrawal Time)
10.9; 11.5
SECONDARY
Ancillary Maneuvers Used to Facilitate Colonoscope Advancement
28; 31

Summary

The goal of this study is to test which colonoscope works best in people who are above a certain body mass index. Currently, both pediatric and adult colonoscopes are accepted as standard treatments in colonoscopies. Endoscopist pick which one to use based on personal preference and what is available.

Eligibility Criteria

Inclusion Criteria

  • BMI greater than 30
  • Screening and surveillance colonoscopy

Exclusion Criteria

  • Colon surgery
  • Therapeutic colonoscopy
  • Inflammatory bowel disease
  • Terminated procedure due to stool burden, stenosis, or obstructive mass.
  • Colonoscopy for anemia
  • History of incomplete colonoscopy due to technical difficulties
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06776913). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search